Guardant Health (GH)
(Delayed Data from NSDQ)
$25.09 USD
-0.30 (-1.18%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $25.10 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Guardant Health (GH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$41.15 | $60.00 | $23.00 | 62.07% |
Price Target
Based on short-term price targets offered by 20 analysts, the average price target for Guardant Health comes to $41.15. The forecasts range from a low of $23.00 to a high of $60.00. The average price target represents an increase of 62.07% from the last closing price of $25.39.
Analyst Price Targets (20)
Broker Rating
Guardant Health currently has an average brokerage recommendation (ABR) of 1.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 21 brokerage firms. The current ABR compares to an ABR of 1.17 a month ago based on 21 recommendations.
Of the 21 recommendations deriving the current ABR, 18 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 85.71% and 9.52% of all recommendations. A month ago, Strong Buy made up 85.71%, while Buy represented 9.52%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 18 | 18 | 18 | 18 | 18 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/5/2024 | Not Identified | Not Identified | Hold | Hold |
8/21/2024 | UBS | Dan Leonard | Strong Buy | Strong Buy |
8/8/2024 | Piper Sandler | David M Westenberg | Strong Buy | Strong Buy |
8/8/2024 | Craig-Hallum | William B Bonello | Strong Buy | Strong Buy |
8/7/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
7/30/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
7/30/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
7/18/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/17/2024 | Goldman Sachs | Matthew Sykes | Strong Buy | Strong Buy |
6/28/2024 | Guggenheim Securities | Subbu Nambi | Hold | Strong Buy |
6/3/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
5/24/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
5/24/2024 | Stephens | Mason Carrico | Strong Buy | Strong Buy |
5/13/2024 | Raymond James | Andrew Cooper | Moderate Buy | Moderate Buy |
5/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/29/2024 | Canaccord Genuity | Kyle Mikson | Strong Buy | Strong Buy |
12/15/2023 | Scotiabank | Sung-Ji Nam | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.17 |
ABR (Last week) | 1.17 |
# of Recs in ABR | 21 |
Average Target Price | $41.15 |
LT Growth Rate | 33.70% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.56 |
GH FAQs
Guardant Health, Inc. (GH) currently has an average brokerage recommendation (ABR) of 1.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 21 brokerage firms.
The average price target for Guardant Health, Inc. (GH) is $41.15. The current on short-term price targets is based on 7 reports.
The forecasts for Guardant Health, Inc. (GH) range from a low of $23 to a high of $60. The average price target represents a increase of $64.01 from the last closing price of $25.09.
The current UPSIDE for Guardant Health, Inc. (GH) is 64.01%
Based on short-term price targets offered by 20 analysts, the average price target for Guardant Health comes to $41.15. The forecasts range from a low of $23.00 to a high of $60.00. The average price target represents an increase of 62.07% from the last closing price of $25.39.